If you're on a GLP-1 weight loss program and are pregnant, planning to become pregnant, or nursing, this is critical information for your care.
Current medical guidance recommends discontinuing GLP-1 medications before and during pregnancy. There is limited clinical data on effects of GLP-1 receptor agonists on fetal development, and the precautionary medical consensus is that these medications should not be used during pregnancy.
Speak with your HolaVida provider. Depending on your health goals and timeline, your provider can help plan appropriate steps — including timing of discontinuation and transition to alternative support.
Similar caution applies to breastfeeding. Data on GLP-1 medication transfer through breast milk is limited, and current guidance generally recommends against using these medications while nursing.
GLP-1 medications can affect how oral medications are absorbed due to slowed gastric emptying. Some providers recommend discussing contraception options if you're using oral contraceptives — alternative methods may be advisable during treatment.
These decisions are personal and medical. HolaVida's licensed providers are here to help you navigate them safely. Visit HolaVida for support.
.svg)
.jpg)
.jpg)
.jpg)
.webp)
.svg)
.avif)
.avif)
.avif)
.avif)
.avif)